Comparison window: 29 Jan 2026 → 3 Sept 2026 (max: from the most recent launch) · currency: 🇪🇺 EUR · inflation: 🇮🇹 Italy · distributions: reinvested where declared⚠ Common window shorter than 12 months: comparable data are scarce and carry no statistical value.
Report produced on 5 September 2026 · data as of the dates shown per section Sources: official issuer documents (KID, factsheet, declared NAV series and holdings), ESMA register, ECB rates, Eurostat Public methodology: rebalix.com/en/methodology
Informational document generated by rebalix.com — facts side by side, no recommendations. It does not constitute investment advice or investment research under Directive 2014/65/EU (MiFID II). Past performance is not indicative of future results.
JMAM — Strategic Allocation Moderate Active UCITS ETF · IE000TWAN2K7 · Multi-asset · Europe
Performance over the period, in euro
From 29 Jan 2026 to 3 Sept 2026 · base 100 · ECB rates, dividends reinvested where declared
In euro (nominal)
In today’s purchasing power (net of Italy inflation)
Same scale in both panels: the gap between endpoints is Italian inflation over the period (Eurostat). Volatility stays nominal, as everywhere on the site.
How far they fell — drawdown from peak (nominal)
In euro · distance from the previous peak, day by day, on NAV: for distributing classes it includes ex-dividend drops (slightly deeper than total return)
Filled area: XEQ8; thin lines: the other funds.
The worst episode, fund by fund
Fund
Max drawdown
Trough
Recovery time
Underwater
XEQ8
−6.6%
30 Mar 2026
18 days
46 days · back to break-even on 17 Apr 2026
JMAM
−5.3%
27 Mar 2026
21 days
51 days · back to break-even on 17 Apr 2026
"Recovery time" = the climb only: trough to break-even (0%). "Underwater" = decline + recovery: peak to break-even.
Drawdown net of Italy inflation
Same curve in purchasing-power terms: as on the site, drawdown follows the real view (volatility stays nominal, per methodology)
In real terms declines are deeper and recoveries slower. Monthly price index (Eurostat), held at the last published value.
JMAM — Strategic Allocation Moderate Active UCITS ETF · IE000TWAN2K7 · Multi-asset · Europe
Metric
XEQ8
JMAM
Note
Identity
Category
Multi-asset
Multi-asset · Europe
Rebalix engine classification
Replication
Gestione attiva (dal KID)
Gestione attiva (dal KID)
as declared by the issuer
Currency hedging
Yes — hedged to EUR
No
source: class name, factsheet
Income policy
accumulating
accumulating
—
Costs
TER
0.24%
0.35%
from the KID
Transaction costs (KID)
0.16%
0.06%
internal
All-in cost
0.40%
0.41%
TER + transaction
Tracking difference (3a)
—
—
vs its OWN index
Performance in euro (ECB rates)
1 year
—
—
—
3 years
—
—
—
5 years
—
—
—
10 years
—
—
— = series younger than the window
Risk · last 3 years
Volatility (ann.)
—
—
—
Max drawdown
—
—
—
Sharpe
—
—
risk-free = ECB MRO avg
Sortino
—
—
like Sharpe, downside only
Italian taxation
Effective capital-gains rate
26.00%
26.00%
white list, current half-year
Documents & exchanges
Listing venues
9
9
ESMA register
Borsa Italiana ticker
XEQ8
JMAM
—
Indicative cumulative cost: on 10,000 euro over 5 years (stated assumption: 5%/yr growth, cost = TER + transaction) ~253 euro XEQ8 · ~260 euro JMAM. Broker costs not included.
Disclaimer
This document is for information only and does not constitute investment advice under Directive 2014/65/EU (MiFID II), investment research, a personal recommendation, or an offer or solicitation to buy or sell financial instruments.
Past performance is not indicative of, nor a guarantee of, future results. The value of an investment can go down as well as up and investors may not get back the capital invested. Euro returns are affected by currency fluctuations.
Before any investment decision, read the KID and the Prospectus, available from the issuers. Tax treatment depends on individual circumstances and may change.
Data come from official issuer documents and public registers, following the public methodology at rebalix.com/en/methodology. "—" fields were not published by the source and have not been estimated. Rebalix receives no compensation from the issuers mentioned.